Treatment of transurethral resection of the prostate.

A clinical trial to compare the outcomes of transurethral resection of the prostate (TURP) and TURP plus Botox injection in patients with benign prostatic hyperplasia (BPH).

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110306005981N3

Enrollment

Registered

2018-12-25

Start date

2019-01-21

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic hyperplasia. Hyperplasia of prostate

Interventions

Intervention 1: Intervention group: The intervention group I will receive of transurethral resection of the prostate treatment. Intervention 2: Intervention group: The intervention group II will recei

Eligibility

Sex/Gender

Male

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age range of 50-80 years Lower urinary tract symptoms resistant to standard medical treatment international prostate symptom score (IPSS) of >12 prostate volume of >50 cm3 in ultrasound

Exclusion criteria

Exclusion criteria: History of prostate surgery Having prostate cancer Having bleeding disorders Incidence of acute urinary retention during the treatment

Design outcomes

Primary

Measure	Time frame
Clinical symptoms (e.g., dysuria, urinary frequency, and pelvic pain). Timepoint: 3, 6, and 12 months after the intervention. Method of measurement: The international prognostic scoring system (IPSS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaliheh Keshvari Shirvan

Mashhad University of Medical Sciences

keshvarim@mums.ac.ir+98 51 1761 5063

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026